Carpal tunnel syndrome. Nerve, nerve root and plexus disorders
Conditions
Interventions
Intervention 1: Control group: Brace and 100mg celebrex tablets, twice daily (morning and night). Intervention 2: Intervention: Acupuncture with 0.25*40 mm size needles on 20 acupoints , 3 times a wee
Treatment - Drugs
Treatment - Other
Control group: Brace and 100mg celebrex tablets, twice daily (morning and night)
Sponsors
Vice Chancellor for Research, Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Major eligibility criteria: Over 20 yrs of age; pain and tingling along the median nerve route; willing to participate in the study. Major exclusion criteria: Polyneuritis or lesions of the cervical radicolopathy; hypothyroidism; multiple myeloma; amyloidosis; inability to perform daily functions individually; previous acupuncture treatment or surgery for CTS; insulin dependent diabetes; pregnancy or less than 3 month post partum; epilepsy; cardiovascular disease; history of gastrointestinal disease and intolerance for NSAIDS; history of warfarin or heparin consumption or a hemorrhagic disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms (pain, numbness, tingling, muscle weakness and night awakening ). Timepoint: 3 months after the intervention. Method of measurement: global symptom score (GSS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Electrodiagnostic tests (CMAP, DML, DSL, MNCV). Timepoint: 3 months after the end of intervention. Method of measurement: repeating the mentioned tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHosein Hasanabadi
Mashhad University of Medical Sciences
Outcome results
None listed